Evidence map›Paper›PMID 41912932›Full record

ArticleNature genetics2026

Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorder.

Daniel Greene, Rodrigo Mendez, Jon Lees, Mafalda Barbosa, Alessandro Bruselles, Luigi Chiriatti, Federico Ferraro, Cecilia Mancini, Rachel Schot, Frank Sleutels and 21 more

Erratum issuedAbstract read
In one paragraph

Article in Nature genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Genetic Diagnosis in Epilepsy: Implications for Clinical Management.Current neurology and neuroscience reports · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Daniel Greene *Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rodrigo Mendez *Department of Medicine, Stanford University, Stanford, CA, USA.
Jon LeesBristol Medical School, University of Bristol, Bristol, UK.
Mafalda BarbosaDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Alessandro BrusellesOncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0002-1556-4998
Luigi ChiriattiMolecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Federico FerraroDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0003-1365-2529
Cecilia ManciniMolecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Rachel SchotDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0001-9578-4095
Frank SleutelsDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0001-6813-5209
Enrico BertiniMuscular and Neurodegenerative Disorders, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0001-9276-4590
Devon E BonnerDepartment of Pediatrics, Stanford University, Stanford, CA, USA.
Arjan BoumanDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Alice S BrooksDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Thomas A CassiniVanderbilt University Medical Center, Nashville, TN, USA.
Kimberly M EzellVanderbilt University Medical Center, Nashville, TN, USA.
Natalia Gomez-OspinaDepartment of Pediatrics, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-6740-1154
Tjitske KleefstraDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Michael O'DonoghueNeurology, Nottingham University Hospital NHS Trust, Nottingham, UK.
Lynette RivesVanderbilt University Medical Center, Nashville, TN, USA.
Vandana ShashiDuke University School of Medicine, Durham, NC, USA.
Rebecca C SpillmannDuke University School of Medicine, Durham, NC, USA.
Mohamed WafikGuy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-9622-5268
Undiagnosed Diseases Network
Kathleen FresonDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-4381-2442
Tahsin Stefan BarakatDepartment of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0003-1231-1562
Marco TartagliaMolecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0001-7736-9672
Jonathan A BernsteinDepartment of Pediatrics, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-5369-346X
Andrew D MumfordBristol Medical School, University of Bristol, Bristol, UK.
Matthew T WheelerDepartment of Medicine, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-8721-3022
Ernest TurroDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ernest.turro@mssm.edu.ORCID http://orcid.org/0000-0002-1820-6563

Funding

An integrated and diverse genomic medicine program for undiagnosed diseasesU01HG007672 · NHGRI · DUKE UNIVERSITY · PI SHASHI, VANDANA · 2014 to 2022
$13.4M
An integrated and diverse genomic medicine program for undiagnosed diseasesU01NS134350 · NINDS · DUKE UNIVERSITY · PI VANDANA SHASHI · 2023 to 2026
$3.6M
Center for Undiagnosed Diseases at StanfordU01NS134358 · NINDS · STANFORD UNIVERSITY · PI Jonathan Adam Bernstein, HOLLY K TABOR · 2023 to 2026
$3.1M
Integrative analysis of whole genomes and transcriptomes from multiple cell types in rare disease patientsR01HL161365 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ernest Turro · 2023 to 2026
$2.6M
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research) 09150172110002NHGRI NIH HHS U01 HG007672NHLBI NIH HHS R01 HL161365NINDS NIH HHS U01 NS134350NINDS NIH HHS U01 NS134358U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL161365U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) U01NS134358Wellcome Trust
6 · The paper itself

Abstract

We recently showed that mutations in the snRNA genes RNU4-2 and RNU2-2 are prevalent causes of dominant neurodevelopmental disorders (NDDs). Here, by genetic association, we demonstrate the existence of a recessive form of RNU2-2 syndrome. We inferred a log Bayes factor for a recessive model of association of 18.2. Conditional on that model, 17 rare variants had a posterior probability of pathogenicity >0.8. This conservative threshold identified 18 probands and 5 affected siblings, each carrying two alleles in trans at these variants. A relaxed threshold of >0.6 identified a further 13 candidate probands. We identified nine further cases in replication collections. Affected individuals have intellectual disability, global developmental delay and seizures. Recessive RNU2-2 syndrome accounts for ~10% of families with a recessive NDD presently diagnosable by sequencing and affects ~60% as many families as the dominant RNU4-2-related NDD ReNU syndrome. The variants are predicted to destabilize stem loops and binding domains of U2-2 snRNA. Whole-blood RNA sequencing data showed a >90% reduction in the expression of pathogenic U2-2 alleles in biallelic cases and monoallelic carriers, albeit with wild-type compensation in carriers, pointing to a loss-of-expression mechanism.

Indexed as

Genes, RecessiveNeurodevelopmental DisordersRNA, Small NuclearAllelesFemaleHumansMutationRNA, Small NuclearRNU4ATAC RNA, human

Identifiers

PMID41912932
PMCPMC13083235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.